SCHEDULE 4
PART IPHARMACY PRACTICES COMMITTEE
Pharmacy Practices CommitteeI11
The Board shall, in accordance with regulation 7 of the Health Boards (Membership and Procedure) (Scotland) Regulations 200148 and the provisions of this Schedule establish a committee (to be known as “the Pharmacy Practices Committee”).
FunctionsI22
The Pharmacy Practices Committee shall on behalf of the Board exercise the functions of the Board in terms of regulation 5(10) and paragraph 3 of Schedule 3.
MembershipI33
1
The Pharmacy Practices Committee shall consist of seven members of whom–
a
one shall be the chair appointed as such by the Board; the chair shall be a member of the Board but shall not be an officer of the Board nor shall the chair be, nor previously have been, a doctor, dentist, ophthalmic optician or pharmacist or the employee of a person who is a doctor, dentist, ophthalmic optician or pharmacist;
b
three shall be pharmacists of whom–
i
one shall be a pharmacist whose name is not included in any pharmaceutical list and who is not the employee of a person whose name is so listed; and such pharmacist shall be appointed by the Board from persons nominated by the F1Area Pharmaceutical Committee; and
ii
two shall be pharmacists each of whom is included in a pharmaceutical list or is an employee of a person whose name is so listed; and each shall be appointed by the Board from persons nominated by the Area Pharmaceutical Committee; and
c
three shall be persons appointed by the Board otherwise than from the members of the Board but none shall be nor previously have been a doctor, dentist, ophthalmic optician or a pharmacist, or an employee of a person who is a doctor, dentist, ophthalmic optician or pharmacist.
F21A
In the circumstances described in sub-paragraph (1B) the Pharmacy Practices Committee shall have an additional member appointed by the Board from persons nominated by the Area Medical Committee.
1B
The circumstances are where the premises that are the subject of the application are located in the same neighbourhood as premises from which a dispensing doctor dispenses.
2
Persons to act as deputies for, and corresponding in number to, each of those categories of person appointed pursuant to sub-paragraph (1) F3and, as the case may be, sub-paragraph (1A) shall, provided they satisfy the criteria specified in that sub-paragraph, be appointed by the Board and in the absence of any of those persons a deputy from the appropriate category shall be entitled to act in the absent person’s place.
3
If a nomination sought for the purposes of sub-paragraph (1)(b)(i) or (ii) F4or sub-paragraph (1A) above is not made before such date as the Board may determine, the Board may appoint as a member a person who satisfies the criteria specified in the relevant sub-paragraph.
4
The Board shall prepare and maintain lists of the persons who have been appointed, in accordance with paragraph 3(1)(a), (b)(i) F5or (ii), (c) or (1A), as the case might be, and who currently serve as members of the Pharmacy Practices Committee, and shall provide the Scottish Ministers with a copy of such lists from time to time.
Declaration of interestI44
1
Before any meeting of the Pharmacy Practices Committee begins the chair, or in the chair’s absence, the person acting as chair, shall ask the members intending to be present whether, in respect of any matter to be considered at the meeting, any of them–
a
has an interest to declare; or
b
is associated with a person who has any personal interest,
and any such member who has or, as the case may be, is associated with a person who has, any such interest shall disclose it accordingly.
2
Any member who has, pursuant to the provisions of sub-paragraph (1) above, disclosed an interest or who, in the opinion, expressed to the meeting, of the chair or in the chair’s absence, the person acting as chair as the case may be, should have disclosed such an interest, shall not be present at the consideration or discussion of that matter or the voting on it, and a deputy who has no such interest may act in that member’s place.
QuorumI55
No business shall be transacted at a meeting of the Pharmacy Practices Committee unless the chair or in the chair’s absence, the person acting as chair, one member appointed under each of paragraph 3(1)(b)(i) and (ii), and two other members appointed under paragraph 3(1)(c) are present.
F17Independent legal assessor5A
1
The Board may appoint an independent legal assessor to assist them in their deliberations, including voting.
2
The independent legal assessor’s role is to provide legal and technical advice and support.
VotingI66
1
Subject to sub-paragraphs (2), (3) and (4) below, every application considered by the Pharmacy Practices Committee shall be considered by all members present, but shall be determined only by a majority of votes of the members present who are entitled to vote.
F62
Except in the circumstances set out in paragraph (4) only a member appointed by virtue of paragraph 3(1)(c) is entitled to vote.
3
A member appointed by virtue of paragraph F73(1)(b) or 3(1A) is not entitled to vote and shall withdraw immediately before a decision on an application by voting takes place.
4
The chair, or in the chair’s absence the person acting as chair, shall not be entitled to vote at any meeting except in the case of an equality of votes of the other persons present and voting, in which case the chair shall have a casting vote.
5
The Pharmacy Practices Committee shall within ten working days of taking its decision give written notification F18to the Board of that decision and the information required under paragraph 3(6) of Schedule 3.
Standing ordersI77
Subject to the provisions of these Regulations, the Board may make, vary or revoke standing orders with respect to the terms of office of members of the Pharmacy Practices Committee, the procedure of that committee and the making of reports of its proceedings to the Board.
VacancyI88
The proceedings of the Pharmacy Practices Committee shall not be invalidated by any vacancy in its membership, or any defect in a member’s appointment.
PART IINATIONAL APPEAL PANEL
Nominees for the National Appeal PanelI99
1
The Board shall submit the names of its nominees for the National Appeal Panel to the Scottish Ministers and shall advise them from time to time of any changes in such nominees.
F82
The persons nominated by the Board under sub-paragraph (1) must not be, nor have been previously, a doctor, dentist, ophthalmic optician or pharmacist nor a person employed by a doctor, dentist, ophthalmic optician or pharmacist.
F9Chair of National Appeal PanelI1010
1
After consultation with all Health Boards, the Scottish Ministers shall appoint a Chair and a substitute Chair of the National Appeal Panel.
2
Each person so appointed—
a
shall be an advocate, a solicitor or a solicitor-advocate; but
b
shall not be, nor previously have been, a doctor, dentist, ophthalmic optician, pharmacist, or person, or employee of a person, whose name is on the pharmaceutical list.
3
Where the person appointed as Chair is unable for whatever reason to fulfil the duties of the Chair, the person appointed as substitute Chair shall take the place of that person and all references to the Chair in these Regulations shall be deemed to refer to the person appointed as substitute Chair
MembershipI1111
1
In any case in which paragraph 5(6) of Schedule 3 falls to be applied, the Scottish Ministers shall arrange to convene in accordance with this paragraph the National Appeal Panel, the members of which shall be drawn from–
F10a
the lists maintained, in accordance with paragraph 3(4), of persons falling within paragraph 3(1)(b)(i); and
b
the nominees proposed in accordance with paragraph 9.
2
No member of the National Appeal Panel shall be a member of–
a
the Board or the Pharmacy Practices Committee of the Board which considered the application; or
b
any Board which was notified in terms of paragraph 1(1)(d) of Schedule 3 and which submitted representations in accordance with that paragraph.
F113
The National Appeal Panel shall consist of three members of whom—
a
one shall be chair appointed as provided for in paragraph 10;
b
one shall be a pharmacist; and
c
one shall be nominated by the Board under paragraph 9.
Declaration of interestI1212
1
Before the start of any meeting of the National Appeal Panel the chair F12... shall ask the members intending to be present whether, in respect of the appeal to be considered at the meeting, any of them–
a
has an interest to declare;
b
is associated with a person who has any personal interest,
and any such member who has or, as the case may be, is associated with the person who has, any such interest shall disclose it accordingly.
2
Any member who has, pursuant to the provisions of sub-paragraph (1) disclosed an interest or who, in the opinion, expressed to the meeting, of the chair F13... should have disclosed such an interest, shall not be present at the consideration or discussion of that appeal or the voting on it.
QuorumF14I1313
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F15VotingI1414
Every appeal must be considered by all members of the National Appeal Panel convened for that purpose and determined by a majority of the votes of those members.
F16Notice of decision of National Appeal PanelI1515
1
The National Appeal Panel shall, within 5 working days of taking its decision, give written notification of that decision with reasons for it to the Board to whom the original application was made.
2
The Board shall—
a
within 5 working days of receipt of such notification, intimate to the applicant and all persons mentioned in paragraph 1 of Schedule 3 that decision and the reasons for it; and
b
within 5 working days of such intimation, publish that decision and the reasons for it on its website.